IDH3A and glioblastoma: Progress in comprehending the genetic and epigenetic modifications of GBM has revealed substantial heterogeneity, characterized by distinct molecular subtypes, such as the isocitrate dehydrogenase (IDH)-mutant (approximately 10%, originating from low-grade glioma) and IDH-wildtype (approximately 90%) subtypes (1).